Traditional medicine, encompassing systems such as Ayurveda, Traditional Chinese Medicine (TCM), Kampo, Unani, Siddha, and various indigenous practices, has been a cornerstone of healthcare for centuries. Despite the dominance of modern medicine, T&CM continues to play a vital role in primary healthcare, with approximately 80% of the global population using it at least occasionally. The World Health Organization (WHO) has been instrumental in promoting integration through its Traditional Medicine Strategies (2014–2023 and 2025–2034), urging member states to develop national policies that ensure the safe, effective, and equitable use of T&CM.
Global Policy Initiatives
Numerous countries have established national policies to support the integration of T&CM. China integrated TCM into its national healthcare system via the 2017 TCM Law, ensuring coverage in 90% of hospitals. India institutionalized traditional systems under the Ministry of AYUSH (Ayurveda, Yoga, Unani, Siddha, Sowa-Rigpa, and Homeopathy), promoting co-location in public hospitals. South Korea implemented a dual licensing system for Korean Medicine and biomedical practitioners, while Brazil integrated 29 traditional practices into its public health system (SUS) through the National Policy on Integrative and Complementary Practices (PNPIC). These initiatives reflect a growing recognition of T&CM's role in enhancing healthcare resilience and addressing chronic diseases.
Regulatory and Institutional Frameworks
Effective integration relies on robust regulatory frameworks governing practitioner licensing, quality control, pharmacovigilance, and research. India's National Commission for Indian System of Medicine regulates education and licensure, while China's National Medical Products Administration oversees quality control of TCM products. Germany includes naturopathy in public health insurance, and Australia regulates complementary medicines through the Therapeutic Goods Administration. These frameworks ensure standardization, safety, and credibility, though disparities in regulation persist globally.
Clinical Integration Models
Four primary models of clinical integration have been identified:
Co-location Model: T&CM practitioners work within conventional healthcare facilities, facilitating multidisciplinary collaboration (e.g., India's AYUSH centers, South Korean hospitals).
Referral-Based Model: Conventional practitioners refer patients to external T&CM providers (common in Germany and Australia).
Fully Integrated Services: T&CM and biomedical practitioners collaborate closely in treatment planning (e.g., China's TCM hospitals, Japan's Kampo integration).
Parallel Model: Patients access both systems independently without formal coordination (e.g., U.S. complementary therapy use).
These models are adapted to local contexts, depending on cultural acceptance, resource availability, and health system infrastructure.
Scientific Validation and Evidence
Growing evidence supports the efficacy of T&CM in managing chronic pain, stress, metabolic disorders, and immune-related conditions. For instance, Ayurvedic herbs like Ashwagandha and Turmeric exhibit anti-inflammatory and immunomodulatory properties. Acupuncture is validated for pain relief, and mind-body practices like Yoga show benefits in mental health. Research initiatives led by institutions such as India's Central Council for Research in Ayurvedic Sciences and the U.S. National Center for Complementary and Integrative Health (NCCIH) have contributed to this evidence base.
Impact and Outcomes
Integrative models improve patient outcomes by enhancing symptom management, quality of life, and treatment adherence. They also promote interprofessional collaboration and reduce healthcare costs by decreasing hospitalization and pharmaceutical dependency. In countries like China and Brazil, integration has improved access to culturally relevant care for marginalized populations.
Challenges and Barriers
Despite progress, integration faces several challenges:
Lack of large-scale scientific validation for many T&CM modalities.
Resistance from biomedical professionals due to safety and efficacy concerns.
Disparities in education and regulation across countries.
Ethical issues related to the commercialization of indigenous knowledge.
Inadequate funding and research support.
Addressing these barriers requires coordinated efforts in evidence generation, regulatory harmonization, interdisciplinary education, and ethical safeguarding.
Conclusion
The integration of traditional and modern medicine offers a promising pathway to more inclusive, patient-centered, and culturally responsive healthcare systems. Successful integration depends on evidence-based policies, robust regulatory frameworks, and adaptable clinical models. Countries like China, India, Brazil, and Germany provide valuable examples for global implementation. Future efforts should focus on international collaboration, standardized education, and ethical practices to realize the full potential of integrative healthcare.
Full text:
https://www.xiahepublishing.com/2835-6357/FIM-2025-00033
The study was recently published in the Future Integrative Medicine .
Future Integrative Medicine (FIM) is the official scientific journal of the Capital Medical University. It is a prominent new journal that promotes future innovation in medicine.It publishes both basic and clinical research, including but not limited to randomized controlled trials, intervention studies, cohort studies, observational studies, qualitative and mixed method studies, animal studies, and systematic reviews.
